Tag Archives: Nixon Peabody

The Biotech Toddler Argument: “Chilling Effect on Innovation” Overplayed?

In last week’s issue of BioWorld Insight, our esteemed Washington editor Mari Serebrov wrote an article titled, “Shorter Exclusivity Could Carry a Hefty Price Tag.” In it, she quoted sources who are very concerned that reducing the current 12-year exclusivity…